Skip to content

Safety and Efficacy of EchoNavigator System Release II During Structural Heart Interventions

Safety and Efficacy of EchoNavigator System Release II (Philips, Andover, MA) During Structural Heart Interventions

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02608008
Acronym
EchoNav
Enrollment
500
Registered
2015-11-18
Start date
2014-09-30
Completion date
2021-06-30
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Imaging Techniques

Keywords

3D-Ultrasound, Live X-rays, EchoNavigator System

Brief summary

The purpose of this study is to collect data regarding the safety and efficacy of EchoNavigator System Release II during structural heart interventions in the clinical practice. Data of procedures with and without the use of EchoNavigator System Release II will be collected, analysed and evaluated.

Detailed description

EchoNavigator System Release II is a CE certified innovative periinterventional imaging modality used in our clinic of cardiology, pulmonology and angiology during structural heart interventions like transfemoral aortic valve Implantation (TAVI), MitraClip implantation, patent foramen ovale (PFO), atrial septal defect (ASD) and left atrial appendage (LAA). During this interventions EchoNavigator is able to combine live X-ray Images and 3D Echo guidance to enhance the efficiency of the procedure. Specific periprocedural data parameter, e.g. procedure duration, radiation time, radiation dose, transseptal punction time (e.g.LAA) and contrast agent amount will be collected and analysed. The same data characteristics from the same procedures but without the periinterventional use of the EchoNavigator System Release II will be collected, analysed and compared with the data described above. A retrospective data collection between 2013 - 2017 of n=500 patients will be conducted.

Interventions

data parameters Analysis

Sponsors

Heinrich-Heine University, Duesseldorf
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult male or female patients of any ethnic origin aged \> 18 years * Signed and dated informed consent for the prospective study part

Exclusion criteria

* \< 18 year

Design outcomes

Primary

MeasureTime frameDescription
Comparison of procedure timebaselineDuring interventions with and without the use of EchoNavigator System Release II

Secondary

MeasureTime frameDescription
Comparison of duration of the transeptal punctionbaselineDuring mitraClip implantations, ASD/PFO with and without the use of EchoNavigator System Release II.
Comparison of area dose productbaselineDuring procedures with and without the use of EchoNavigator System Release II
Comparison of contrast agent amountbaselineDuring procedures with and without the use of EchoNavigator System Release II
Comparison of data measurements of fluoroscopy timebaselineDuring procedures with and without the use of EchoNavigator System Release II

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026